This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$11.5M
Filings
121
Firms Hired
2
Active Period
2005–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Firm: ZIMMER BIOMET, INC.
Breakthrough devices- H.R. 5343;
Client expense: $180,000 · Firm income: —
Matched citations: H.R. 5343
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.
2026 · second_quarter · Firm: ZIMMER BIOMET, INC.
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;
Client expense: $190,000 · Firm income: —
Matched citations: H.R. 3006
Medicare Beneficiary Co-Pay Fairness Act
2026 · second_quarter · Firm: ZIMMER BIOMET, INC.
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;
Client expense: $190,000 · Firm income: —
Matched citations: S. 1776
Medical Device Electronic Labeling Act
2025 · second_quarter · Firm: ZIMMER BIOMET, INC.
Medical Device Electronic Labeling Act (H.R. 1539)
Client expense: $190,000 · Firm income: —
Matched citations: H.R. 1539
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2023 · fourth_quarter · Firm: ZIMMER BIOMET, INC.
HR 1691; Medicare and Medicaid Treatment (EMMT) Act; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Disparities in Healthcare Coverage for Underserved Populations
Client expense: $180,000 · Firm income: —
Matched citations: HR 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2023 · third_quarter · Firm: ZIMMER BIOMET, INC.
Outpatient Surgical Quality and Access Act; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Food and Drug Administration Regulatory Issues
Client expense: $170,000 · Firm income: —
Matched citations: H.R. 1691
Improving Seniors’ Timely Access to Care Act of 2019
2020 · second_quarter · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Client expense: $90,000 · Firm income: —
Matched citations: HR 3107
Minority Community Public Health Emergency Response Act of 2020
2020 · fourth_quarter · Firm: CAPITOL ASSOCIATES, INC.
The Equality in Medicare and Medicaid Treatment Act HHS and CMS Office of Minority Health Health Disparities as they relate to Medicare payment policy Health Disparities due to race, gender, ethnicity or geography Alternative Payment Models and how they address health disparities Medicare bundled payments and potential to discriminate based on race, ethnicity, gender, geography COVID-19 and impact on minority community H.R. 7546, Minority Community Public Health Emergency Response Act of 2020
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7546
Improving Seniors’ Timely Access to Care Act of 2019
2020 · second_quarter · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Client expense: $90,000 · Firm income: —
Matched citations: HR 3107
Minority Community Public Health Emergency Response Act of 2020
2020 · third_quarter · Firm: CAPITOL ASSOCIATES, INC.
The Equality in Medicare and Medicaid Treatment Act HHS and CMS Office of Minority Health Health Disparities as they relate to Medicare payment policy Health Disparities due to race, gender, ethnicity or geography Alternative Payment Models and how they address health disparities Medicare bundled payments and potential to discriminate based on race, ethnicity, gender, geography COVID-19 and impact on minority community H.R. 7546, Minority Community Public Health Emergency Response Act of 2020
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7546
Improving Seniors’ Timely Access to Care Act of 2019
2020 · third_quarter · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Client expense: $110,000 · Firm income: —
Matched citations: HR 3107
Improving Seniors’ Timely Access to Care Act of 2019
2020 · second_quarter · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Client expense: $90,000 · Firm income: —
Matched citations: HR 3107
Protect Medical Innovation Act of 2019
2020 · first_quarter · Firm: ZIMMER BIOMET, INC.
Medical Device tax Repeal (S. 692), Corporate Tax, health provider funding
Client expense: $100,000 · Firm income: —
Matched citations: S. 692
Protect Medical Innovation Act of 2019
2019 · fourth_quarter · Firm: ZIMMER BIOMET, INC.
Medical Device tax Repeal (S. 692), Corporate Tax
Client expense: $140,000 · Firm income: —
Matched citations: S. 692
Protect Medical Innovation Act of 2019
2019 · third_quarter · Firm: ZIMMER BIOMET, INC.
Medical Device tax Repeal (S. 692), FDARA Implementation
Client expense: $110,000 · Firm income: —
Matched citations: S. 692
Protect Medical Innovation Act of 2019
2019 · second_quarter · Firm: ZIMMER BIOMET, INC.
Medical Device tax Repeal (S. 692), FDARA Implementation
Client expense: $110,000 · Firm income: —
Matched citations: S. 692
Protect Medical Innovation Act of 2019
2019 · first_quarter · Firm: ZIMMER BIOMET, INC.
Medical Device tax Repeal (S. 692), FDARA Implementation
Client expense: $160,000 · Firm income: —
Matched citations: S. 692
Protect Medical Innovation Act of 2019
2019 · first_quarter · Firm: ZIMMER BIOMET, INC.
Tax Reform Technical Corrections, Medical Device Tax Repeal (S.692)
Client expense: $160,000 · Firm income: —
Matched citations: S.692
Equality in Medicare and Medicaid Treatment Act of 2018
2018 · fourth_quarter · Firm: CAPITOL ASSOCIATES, INC.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015 Issues related to health disparities and social determinants of health. Medicare bundled payments and the potential for physicians to "lemon drop" patients who represent high risk, in particular minority patients. Review of alternative payment models and Medicare demonstration programs putting physician payments at risk for clinical decisions. Development of legislation to mandate that CMS consider health disparities and health access as part of the process for evaluating alternative payment models DRAFT legislation to direct CMMI to consider health disparities when reviewing alternative payment models Support for H.R. 6601, the Equality in Medicare and Medicaid Treatment Act of 2018
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6601
Equality in Medicare and Medicaid Treatment Act of 2018
2018 · third_quarter · Firm: CAPITOL ASSOCIATES, INC.
Regulations implementing the Medicare Access and CHIP Reauthorization Act of 2015 Issues related to health disparities and social determinants of health. Medicare bundled payments and the potential for physicians to "lemon drop" patients who represent high risk, in particular minority patients. Review of alternative payment models and Medicare demonstration programs putting physician payments at risk for clinical decisions. Development of legislation to mandate that CMS consider health disparities and health access as part of the process for evaluating alternative payment models DRAFT legislation to direct CMMI to consider health disparities when reviewing alternative payment models Support for H.R. 6601, the Equality in Medicare and Medicaid Treatment Act of 2018
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6601
To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.
2017 · third_quarter · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Client expense: $135,000 · Firm income: —
Matched citations: HR1736
FDA Reauthorization Act of 2017
2017 · third_quarter · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Client expense: $135,000 · Firm income: —
Matched citations: HR 2430
A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications.
2017 · third_quarter · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Client expense: $135,000 · Firm income: —
Matched citations: S404
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Client expense: $135,000 · Firm income: —
Matched citations: S934
To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.
2017 · second_quarter · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Client expense: $190,000 · Firm income: —
Matched citations: HR1736
Source: Senate LDA